Oaktree Acquisition Corp. III Life Sciences
OACCWNasdaq
$0.98
↓ -6.7%Jul 17 close · end-of-day
Price
1Y↑ +8.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
—
Enterprise Value
—
P/E
—
P/S
—
P/B
—
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
$7.0M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-97.2%
ROIC
—
Debt / Equity
—
Net Cash
$1.3M
Return 1Y
+15.9%
Earnings
OACCW Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2025 |
|---|---|
| Revenue | — |
| Gross profit | — |
| Operating income | -$1.2M |
| Net income | $7.3M |
| Diluted EPS | — |
| Operating cash flow | -$422,079.00 |
| Free cash flow | — |
| Gross margin | — |
| Operating margin | — |
| Net margin | — |
| Line item | Q3 '24 | Q '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — |
| Operating income | -$48,095.00 | -$303,711.00 | -$444,802.00 | -$269,810.00 | -$225,579.00 | -$255,496.00 | -$456,538.00 |
| Net income | -$48,095.00 | $1.4M | $1.7M | $1.9M | $2.0M | $1.8M | $1.4M |
| Diluted EPS | — | — | — | — | — | — | — |
| Operating cash flow | $0.00 | -$89,687.00 | -$75,561.00 | -$146,124.00 | -$56,518.00 | -$143,876.00 | -$158,035.00 |
| Free cash flow | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — |
Company news
Coming soonHeadlines for OACCW will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.